NCT05839613View on ClinicalTrials.gov

PhaRmacOgenetics and Therapeutic Drug Monitoring In SchizophrEnia

NANot yet recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Patients With Schizophrenia
Interventions
DIAGNOSTIC_TEST

Therapeutic Drug Monitoring (TDM) and Pharmacogenetics (PG)

Pharmacogenetics (PG) is the study of genetic differences in drug met-abolic pathways Therapeutic Drug Monitoring (TDM) is the quantification and interpre-tation of drug concentration in blood to optimize pharmacotherapy

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT05839613 - PhaRmacOgenetics and Therapeutic Drug Monitoring In SchizophrEnia | Biotech Hunter | Biotech Hunter